BioNTech SE (BNTX)

NasdaqGS • Currently up 1.88 (+1.85%) in today's trading session

1 member of Congress has disclosed 3 trades in BioNTech SE (BNTX) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 7 December 2023. Aggregate disclosed activity totals roughly $24K in purchases (midpoint estimates from bracketed disclosure amounts).

BioNTech SE is currently trading at $103.45, positioned at 54% of its 52-week range ($79.52 – $124.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$103.45
24h Change
+1.88 (+1.85%)
52 Week Range
$79.52—$124.00
View on NASDAQ

BioNTech SE Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BNTX

Select to highlight on chart
3 transactions
Compliance: 100%
Josh Gottheimer7 Dec 20237 Jan 2024PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer6 Dec 20237 Jan 2024PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer5 Dec 20237 Jan 2024PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$26B

Volume

674.8K

Beta

1.59

P/E Ratio

-18.81

Fundamentals

EPS

$-5.50

Div. Yield

—

Open

$102.30

Day Range

$102.30 — $104.81

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
DE
CEO
Ugur Sahin
IPO Date
2019-10-10
Website
www.biontech.de

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanom...

Earnings

Next Report

Q1 2026

5 May

EPS Est.

$-2.52

Rev. Est.

$207.4M

Days Until

5

Recent Quarters

Q4 202510 Mar
EPS$-0.38
Miss 72.7%
Q3 20253 Nov
EPS$-0.14
Beat 87.5%
Q2 20254 Aug
EPS$-1.82
Beat 32.3%
Q1 20255 May
EPS$-1.82
Beat 26.6%
Q4 202410 Mar
EPS$1.15
Beat 148.7%
Q3 20244 Nov
EPS$0.89
Beat 151.1%
Q2 20245 Aug
EPS$-3.62
Miss 65.2%
Q1 20246 May
EPS$-1.42
Miss 5.8%
Q4 202320 Mar
EPS$2.05
Miss 21.8%
Q3 20236 Nov
EPS$0.73
Beat 217.0%
Q2 20237 Aug
EPS$-0.86
Beat 5.4%
Q1 20238 May
EPS$2.20
Beat 665.8%
Q4 202227 Mar
EPS$9.46
Beat 13.7%
Q3 20227 Nov
EPS$7.04
Beat 110.2%
Q2 20228 Aug
EPS$7.31
Miss 1.5%
Q1 20229 May
EPS$15.98
Beat 57.6%
Q4 202130 Mar
EPS$13.93
Beat 64.7%
Q3 20219 Nov
EPS$14.56
Beat 23.5%
Q2 20219 Aug
EPS$12.98
Beat 55.5%
Q1 202110 May
EPS$5.29
Beat 22.7%
Q4 202030 Mar
EPS$1.87
Beat 428.1%
Q3 202010 Nov
EPS$-1.03
Miss 123.9%
Q2 202011 Aug
EPS$-0.42
Miss 44.8%
Q1 202012 May
EPS$-0.26
Beat 13.3%
Q3 201931 Dec
EPS$-0.29
Q3 201914 Nov
EPS$-0.16
Beat 23.8%
Q1 201930 Jun
EPS$-0.25
Q4 201831 Mar
EPS$-0.20
Q3 201831 Dec
EPS$-0.01
Q2 201830 Sept
EPS$-0.12
Q1 201830 Jun
EPS$-0.07
Q4 201731 Mar
EPS$-0.07

Dividends

Dividend History

2 Jun 2022
Amount $2.1110

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVDA

NVIDIA Corporation

20
$199.57-9.68 (-4.63%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.680.00 (0.00%)
Held by same politician
1 politician
View Stock

GOOG

Alphabet Inc.

17
$381.94+34.63 (+9.97%)
Communication Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about BNTX

Which members of Congress have traded BNTX?
1 member of Congress has disclosed 3 trade in BioNTech SE (BNTX) under the STOCK Act: Josh Gottheimer.
When was BNTX most recently disclosed by Congress?
The most recent BNTX disclosure was a purchase by Josh Gottheimer on 7 December 2023.
What is the total disclosed congressional trading volume for BNTX?
Members of Congress have disclosed approximately $24K in BNTX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in BNTX?
This BNTX page updates as soon as new STOCK Act disclosures are filed for BioNTech SE. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.